Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

Identification of osimertinib-resistant EGFR L792 mutations by cfDNA sequencing: oncogenic activity assessment and prevalence in large cfDNA cohort.

Fairclough SR, Kiedrowski LA, Lin JJ, Zelichov O, Tarcic G, Stinchcombe TE, Odegaard JI, Lanman RB, Shaw AT, Nagy RJ.

Exp Hematol Oncol. 2019 Oct 11;8:24. doi: 10.1186/s40164-019-0148-7. eCollection 2019.

2.

Validation of Microsatellite Instability Detection Using a Comprehensive Plasma-Based Genotyping Panel.

Willis J, Lefterova MI, Artyomenko A, Kasi PM, Nakamura Y, Mody K, Catenacci DVT, Fakih M, Barbacioru C, Zhao J, Sikora M, Fairclough SR, Lee H, Kim KM, Kim ST, Kim J, Gavino D, Benavides M, Peled N, Nguyen T, Cusnir M, Eskander RN, Azzi G, Yoshino T, Banks KC, Raymond VM, Lanman RB, Chudova DI, Talasaz A, Kopetz S, Lee J, Odegaard JI.

Clin Cancer Res. 2019 Dec 1;25(23):7035-7045. doi: 10.1158/1078-0432.CCR-19-1324. Epub 2019 Aug 4.

PMID:
31383735
3.

Tumor Genomic Profiling Guides Patients with Metastatic Gastric Cancer to Targeted Treatment: The VIKTORY Umbrella Trial.

Lee J, Kim ST, Kim K, Lee H, Kozarewa I, Mortimer PGS, Odegaard JI, Harrington EA, Lee J, Lee T, Oh SY, Kang JH, Kim JH, Kim Y, Ji JH, Kim YS, Lee KE, Kim J, Sohn TS, An JY, Choi MG, Lee JH, Bae JM, Kim S, Kim JJ, Min YW, Min BH, Kim NKD, Luke S, Kim YH, Hong JY, Park SH, Park JO, Park YS, Lim HY, Talasaz A, Hollingsworth SJ, Kim KM, Kang WK.

Cancer Discov. 2019 Oct;9(10):1388-1405. doi: 10.1158/2159-8290.CD-19-0442. Epub 2019 Jul 17.

PMID:
31315834
4.

Clinical Utility of Comprehensive Cell-free DNA Analysis to Identify Genomic Biomarkers in Patients with Newly Diagnosed Metastatic Non-small Cell Lung Cancer.

Leighl NB, Page RD, Raymond VM, Daniel DB, Divers SG, Reckamp KL, Villalona-Calero MA, Dix D, Odegaard JI, Lanman RB, Papadimitrakopoulou VA.

Clin Cancer Res. 2019 Aug 1;25(15):4691-4700. doi: 10.1158/1078-0432.CCR-19-0624. Epub 2019 Apr 15.

PMID:
30988079
5.

Plasma HER2 (ERBB2) Copy Number Predicts Response to HER2-targeted Therapy in Metastatic Colorectal Cancer.

Siravegna G, Sartore-Bianchi A, Nagy RJ, Raghav K, Odegaard JI, Lanman RB, Trusolino L, Marsoni S, Siena S, Bardelli A.

Clin Cancer Res. 2019 May 15;25(10):3046-3053. doi: 10.1158/1078-0432.CCR-18-3389. Epub 2019 Feb 26.

PMID:
30808777
6.

IPSE, a parasite-derived host immunomodulatory protein, is a potential therapeutic for hemorrhagic cystitis.

Zee RS, Mbanefo EC, Le LH, Pennington LF, Odegaard JI, Jardetzky TS, Alouffi A, Akinwale J, Falcone FH, Hsieh MH.

Am J Physiol Renal Physiol. 2019 Jun 1;316(6):F1133-F1140. doi: 10.1152/ajprenal.00468.2018. Epub 2019 Feb 20.

PMID:
30785353
7.

IPSE, a urogenital parasite-derived immunomodulatory protein, ameliorates ifosfamide-induced hemorrhagic cystitis through downregulation of pro-inflammatory pathways.

Mbanefo EC, Le L, Zee R, Banskota N, Ishida K, Pennington LF, Odegaard JI, Jardetzky TS, Alouffi A, Falcone FH, Hsieh MH.

Sci Rep. 2019 Feb 7;9(1):1586. doi: 10.1038/s41598-018-38274-z.

8.

Identification of Incidental Germline Mutations in Patients With Advanced Solid Tumors Who Underwent Cell-Free Circulating Tumor DNA Sequencing.

Slavin TP, Banks KC, Chudova D, Oxnard GR, Odegaard JI, Nagy RJ, Tsang KWK, Neuhausen SL, Gray SW, Cristofanilli M, Rodriguez AA, Bardia A, Leyland-Jones B, Janicek MF, Lilly M, Sonpavde G, Lee CE, Lanman RB, Meric-Bernstam F, Kurzrock R, Weitzel JN.

J Clin Oncol. 2018 Oct 19:JCO1800328. doi: 10.1200/JCO.18.00328. [Epub ahead of print]

PMID:
30339520
9.

Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer.

Kim ST, Cristescu R, Bass AJ, Kim KM, Odegaard JI, Kim K, Liu XQ, Sher X, Jung H, Lee M, Lee S, Park SH, Park JO, Park YS, Lim HY, Lee H, Choi M, Talasaz A, Kang PS, Cheng J, Loboda A, Lee J, Kang WK.

Nat Med. 2018 Sep;24(9):1449-1458. doi: 10.1038/s41591-018-0101-z. Epub 2018 Jul 16.

PMID:
30013197
10.

The Landscape of Actionable Genomic Alterations in Cell-Free Circulating Tumor DNA from 21,807 Advanced Cancer Patients.

Zill OA, Banks KC, Fairclough SR, Mortimer SA, Vowles JV, Mokhtari R, Gandara DR, Mack PC, Odegaard JI, Nagy RJ, Baca AM, Eltoukhy H, Chudova DI, Lanman RB, Talasaz A.

Clin Cancer Res. 2018 Aug 1;24(15):3528-3538. doi: 10.1158/1078-0432.CCR-17-3837. Epub 2018 May 18.

11.

Validation of a Plasma-Based Comprehensive Cancer Genotyping Assay Utilizing Orthogonal Tissue- and Plasma-Based Methodologies.

Odegaard JI, Vincent JJ, Mortimer S, Vowles JV, Ulrich BC, Banks KC, Fairclough SR, Zill OA, Sikora M, Mokhtari R, Abdueva D, Nagy RJ, Lee CE, Kiedrowski LA, Paweletz CP, Eltoukhy H, Lanman RB, Chudova DI, Talasaz A.

Clin Cancer Res. 2018 Aug 1;24(15):3539-3549. doi: 10.1158/1078-0432.CCR-17-3831. Epub 2018 Apr 24.

12.

Therapeutic exploitation of IPSE, a urogenital parasite-derived host modulatory protein, for chemotherapy-induced hemorrhagic cystitis.

Mbanefo EC, Le L, Pennington LF, Odegaard JI, Jardetzky TS, Alouffi A, Falcone FH, Hsieh MH.

FASEB J. 2018 Aug;32(8):4408-4419. doi: 10.1096/fj.201701415R. Epub 2018 Apr 3.

13.

Transplant Virus Detection Using Multiplex Targeted Sequencing.

Tan SK, Shen P, Lefterova MI, Sahoo MK, Fung E, Odegaard JI, Davis RW, Pinsky BA, Scharfe C.

J Appl Lab Med. 2018 Mar;2(5):757-769. doi: 10.1373/jalm.2017.024521.

14.

Perinatal Licensing of Thermogenesis by IL-33 and ST2.

Odegaard JI, Lee MW, Sogawa Y, Bertholet AM, Locksley RM, Weinberg DE, Kirichok Y, Deo RC, Chawla A.

Cell. 2017 Dec 14;171(7):1707. doi: 10.1016/j.cell.2017.12.003. No abstract available.

15.

Discrimination of Germline EGFR T790M Mutations in Plasma Cell-Free DNA Allows Study of Prevalence Across 31,414 Cancer Patients.

Hu Y, Alden RS, Odegaard JI, Fairclough SR, Chen R, Heng J, Feeney N, Nagy RJ, Shah J, Ulrich B, Gutierrez M, Lanman RB, Garber JE, Paweletz CP, Oxnard GR.

Clin Cancer Res. 2017 Dec 1;23(23):7351-7359. doi: 10.1158/1078-0432.CCR-17-1745. Epub 2017 Sep 25.

16.

Questions Regarding "CD74-ROS1 Fusion in NSCLC Detected by Hybrid Capture-Based Tissue Genomic Profiling and ctDNA Assays".

Banks KC, Odegaard JI, Lanman RB.

J Thorac Oncol. 2017 Aug;12(8):e127-e128. doi: 10.1016/j.jtho.2017.04.016. No abstract available.

17.

Laser-Assisted Removal of Embedded Vena Cava Filters: A 5-Year First-in-Human Study.

Kuo WT, Odegaard JI, Rosenberg JK, Hofmann LV.

Chest. 2017 Feb;151(2):417-424. doi: 10.1016/j.chest.2016.09.029. Epub 2016 Oct 8.

PMID:
27729265
18.

Perinatal Licensing of Thermogenesis by IL-33 and ST2.

Odegaard JI, Lee MW, Sogawa Y, Bertholet AM, Locksley RM, Weinberg DE, Kirichok Y, Deo RC, Chawla A.

Cell. 2016 Aug 11;166(4):841-854. doi: 10.1016/j.cell.2016.06.040. Epub 2016 Jul 21. Erratum in: Cell. 2017 Dec 14;171(7):1707.

19.

Computational deconvolution of gene expression by individual host cellular subsets from microarray analyses of complex, parasite-infected whole tissues.

Banskota N, Odegaard JI, Rinaldi G, Hsieh MH.

Int J Parasitol. 2016 Jun;46(7):447-52. doi: 10.1016/j.ijpara.2016.02.003. Epub 2016 Mar 26.

PMID:
27025770
20.

Next-Generation Molecular Testing of Newborn Dried Blood Spots for Cystic Fibrosis.

Lefterova MI, Shen P, Odegaard JI, Fung E, Chiang T, Peng G, Davis RW, Wang W, Kharrazi M, Schrijver I, Scharfe C.

J Mol Diagn. 2016 Mar;18(2):267-82. doi: 10.1016/j.jmoldx.2015.11.005. Epub 2016 Feb 1.

21.

Comparison of RELMα and RELMβ Single- and Double-Gene-Deficient Mice Reveals that RELMα Expression Dictates Inflammation and Worm Expulsion in Hookworm Infection.

Chen G, Wang SH, Jang JC, Odegaard JI, Nair MG.

Infect Immun. 2016 Mar 24;84(4):1100-1111. doi: 10.1128/IAI.01479-15. Print 2016 Apr.

22.

Type 2 responses at the interface between immunity and fat metabolism.

Odegaard JI, Chawla A.

Curr Opin Immunol. 2015 Oct;36:67-72. doi: 10.1016/j.coi.2015.07.003. Epub 2015 Jul 21. Review.

23.

Alterations in DNA methylation may be the key to early detection and treatment of schistosomal bladder cancer.

Conti SL, Honeycutt J, Odegaard JI, Gonzalgo ML, Hsieh MH.

PLoS Negl Trop Dis. 2015 Jun 4;9(6):e0003696. doi: 10.1371/journal.pntd.0003696. eCollection 2015 Jun. No abstract available.

24.

Activated type 2 innate lymphoid cells regulate beige fat biogenesis.

Lee MW, Odegaard JI, Mukundan L, Qiu Y, Molofsky AB, Nussbaum JC, Yun K, Locksley RM, Chawla A.

Cell. 2015 Jan 15;160(1-2):74-87. doi: 10.1016/j.cell.2014.12.011. Epub 2014 Dec 24.

25.

Macrophages are required for host survival in experimental urogenital schistosomiasis.

Fu CL, Odegaard JI, Hsieh MH.

FASEB J. 2015 Jan;29(1):193-207. doi: 10.1096/fj.14-259572. Epub 2014 Oct 28.

26.

Identification of Orai1 channel inhibitors by using minimal functional domains to screen small molecule microarrays.

Sadaghiani AM, Lee SM, Odegaard JI, Leveson-Gower DB, McPherson OM, Novick P, Kim MR, Koehler AN, Negrin R, Dolmetsch RE, Park CY.

Chem Biol. 2014 Oct 23;21(10):1278-1292. doi: 10.1016/j.chembiol.2014.08.016. Epub 2014 Oct 9.

27.

Immune responses to Schistosoma haematobium infection.

Odegaard JI, Hsieh MH.

Parasite Immunol. 2014 Sep;36(9):428-38. doi: 10.1111/pim.12084. Review.

28.

Eosinophils and type 2 cytokine signaling in macrophages orchestrate development of functional beige fat.

Qiu Y, Nguyen KD, Odegaard JI, Cui X, Tian X, Locksley RM, Palmiter RD, Chawla A.

Cell. 2014 Jun 5;157(6):1292-308. doi: 10.1016/j.cell.2014.03.066.

29.

Identification of recurrent SMO and BRAF mutations in ameloblastomas.

Sweeney RT, McClary AC, Myers BR, Biscocho J, Neahring L, Kwei KA, Qu K, Gong X, Ng T, Jones CD, Varma S, Odegaard JI, Sugiyama T, Koyota S, Rubin BP, Troxell ML, Pelham RJ, Zehnder JL, Beachy PA, Pollack JR, West RB.

Nat Genet. 2014 Jul;46(7):722-5. doi: 10.1038/ng.2986. Epub 2014 May 25. Erratum in: Nat Genet. 2015 Jan;47(1):97.

30.

A new role for the brain in metabolic control.

Carvalheira JB, Odegaard JI, Chawla A.

Nat Med. 2014 May;20(5):472-3. doi: 10.1038/nm.3556. No abstract available.

PMID:
24804753
31.

A new mouse model for female genital schistosomiasis.

Richardson ML, Fu CL, Pennington LF, Honeycutt JD, Odegaard JI, Hsieh YJ, Hammam O, Conti SL, Hsieh MH.

PLoS Negl Trop Dis. 2014 May 1;8(5):e2825. doi: 10.1371/journal.pntd.0002825. eCollection 2014 May. Erratum in: PLoS Negl Trop Dis. 2014 May;8(5):e2957. Odegaard, Justin L [corrected to Odegaard, Justin I].

32.

Cellular origin of bladder neoplasia and tissue dynamics of its progression to invasive carcinoma.

Shin K, Lim A, Odegaard JI, Honeycutt JD, Kawano S, Hsieh MH, Beachy PA.

Nat Cell Biol. 2014 May;16(5):469-78. doi: 10.1038/ncb2956. Epub 2014 Apr 20. Erratum in: Nat Cell Biol. 2014 Jun;16(6):620.

33.

Old HDL learns a new (anti-inflammatory) trick.

Odegaard JI, Chawla A.

Nat Immunol. 2014 Feb;15(2):138-9. doi: 10.1038/ni.2798. No abstract available.

PMID:
24448572
34.

Adipose tissue macrophages: Amicus adipem?

Odegaard JI, Ganeshan K, Chawla A.

Cell Metab. 2013 Dec 3;18(6):767-8. doi: 10.1016/j.cmet.2013.11.011.

35.

Excimer laser-assisted removal of embedded inferior vena cava filters: a single-center prospective study.

Kuo WT, Odegaard JI, Rosenberg JK, Hofmann LV.

Circ Cardiovasc Interv. 2013 Oct 1;6(5):560-6. doi: 10.1161/CIRCINTERVENTIONS.113.000665. Epub 2013 Sep 24.

PMID:
24065445
36.

Eosinophils secrete IL-4 to facilitate liver regeneration.

Goh YP, Henderson NC, Heredia JE, Red Eagle A, Odegaard JI, Lehwald N, Nguyen KD, Sheppard D, Mukundan L, Locksley RM, Chawla A.

Proc Natl Acad Sci U S A. 2013 Jun 11;110(24):9914-9. doi: 10.1073/pnas.1304046110. Epub 2013 May 28.

37.

The immune system as a sensor of the metabolic state.

Odegaard JI, Chawla A.

Immunity. 2013 Apr 18;38(4):644-54. doi: 10.1016/j.immuni.2013.04.001. Review.

38.

Complex retrieval of fractured, embedded, and penetrating inferior vena cava filters: a prospective study with histologic and electron microscopic analysis.

Kuo WT, Robertson SW, Odegaard JI, Hofmann LV.

J Vasc Interv Radiol. 2013 May;24(5):622-630.e1; quiz 631. doi: 10.1016/j.jvir.2013.01.008. Epub 2013 Mar 21.

PMID:
23523157
39.

Pleiotropic actions of insulin resistance and inflammation in metabolic homeostasis.

Odegaard JI, Chawla A.

Science. 2013 Jan 11;339(6116):172-7. doi: 10.1126/science.1230721. Review.

40.

Transcriptional profiling of the bladder in urogenital schistosomiasis reveals pathways of inflammatory fibrosis and urothelial compromise.

Ray D, Nelson TA, Fu CL, Patel S, Gong DN, Odegaard JI, Hsieh MH.

PLoS Negl Trop Dis. 2012;6(11):e1912. doi: 10.1371/journal.pntd.0001912. Epub 2012 Nov 29.

41.

Leukocyte set points in metabolic disease.

Odegaard JI, Chawla A.

F1000 Biol Rep. 2012;4:13. doi: 10.3410/B4-13. Epub 2012 Jul 2.

42.

Comparison of the acute inflammatory response of two commercial platelet-rich plasma systems in healthy rabbit tendons.

Dragoo JL, Braun HJ, Durham JL, Ridley BA, Odegaard JI, Luong R, Arnoczky SP.

Am J Sports Med. 2012 Jun;40(6):1274-81. doi: 10.1177/0363546512442334. Epub 2012 Apr 10.

PMID:
22495144
43.

A novel mouse model of Schistosoma haematobium egg-induced immunopathology.

Fu CL, Odegaard JI, Herbert DR, Hsieh MH.

PLoS Pathog. 2012;8(3):e1002605. doi: 10.1371/journal.ppat.1002605. Epub 2012 Mar 29.

44.

Connecting type 1 and type 2 diabetes through innate immunity.

Odegaard JI, Chawla A.

Cold Spring Harb Perspect Med. 2012 Mar;2(3):a007724. doi: 10.1101/cshperspect.a007724. Review.

45.

Photothermal ablation with the excimer laser sheath technique for embedded inferior vena cava filter removal: initial results from a prospective study.

Kuo WT, Odegaard JI, Louie JD, Sze DY, Unver K, Kothary N, Rosenberg JK, Hovsepian DM, Hwang GL, Hofmann LV.

J Vasc Interv Radiol. 2011 Jun;22(6):813-23. doi: 10.1016/j.jvir.2011.01.459. Epub 2011 May 6.

PMID:
21530309
46.

IL-4/STAT6 immune axis regulates peripheral nutrient metabolism and insulin sensitivity.

Ricardo-Gonzalez RR, Red Eagle A, Odegaard JI, Jouihan H, Morel CR, Heredia JE, Mukundan L, Wu D, Locksley RM, Chawla A.

Proc Natl Acad Sci U S A. 2010 Dec 28;107(52):22617-22. doi: 10.1073/pnas.1009152108. Epub 2010 Dec 13.

47.

Alternative macrophage activation and metabolism.

Odegaard JI, Chawla A.

Annu Rev Pathol. 2011;6:275-97. doi: 10.1146/annurev-pathol-011110-130138. Review.

48.

PPAR-delta senses and orchestrates clearance of apoptotic cells to promote tolerance.

Mukundan L, Odegaard JI, Morel CR, Heredia JE, Mwangi JW, Ricardo-Gonzalez RR, Goh YP, Eagle AR, Dunn SE, Awakuni JU, Nguyen KD, Steinman L, Michie SA, Chawla A.

Nat Med. 2009 Nov;15(11):1266-72. doi: 10.1038/nm.2048. Epub 2009 Oct 18.

49.

Mechanisms of macrophage activation in obesity-induced insulin resistance.

Odegaard JI, Chawla A.

Nat Clin Pract Endocrinol Metab. 2008 Nov;4(11):619-26. doi: 10.1038/ncpendmet0976. Epub 2008 Oct 7. Review.

50.

Alternative M2 activation of Kupffer cells by PPARdelta ameliorates obesity-induced insulin resistance.

Odegaard JI, Ricardo-Gonzalez RR, Red Eagle A, Vats D, Morel CR, Goforth MH, Subramanian V, Mukundan L, Ferrante AW, Chawla A.

Cell Metab. 2008 Jun;7(6):496-507. doi: 10.1016/j.cmet.2008.04.003.

Supplemental Content

Loading ...
Support Center